The Evans’ Index revisited: New cut-off levels for use in radiological assessment of ventricular enlargement in the elderly

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 01, 2017
Source ID
10.1016/j.ejrad.2017.07.013

Entities

People

  • Andrew D Simmons
  • Christian M. Page
  • Eric Westman
  • Geir Andre Ringstad
  • Kari Wagner-larsen
  • Maiken K. Brix
  • Mona K. Beyer
  • Per Kristian Eide
  • Valeria Vitelli

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • Alzheimer's Research UK
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • Foundation for the National Institutes of Health
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson
  • Johnson & Johnson Pharmaceutical Research and Development
  • King's College London
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute for Health and Care Research
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense
  • Western Norway Regional Health Authority